Celecoxib pathways: pharmacokinetics and pharmacodynamics.

Subjects

Subjects :

Anti-Inflammatory Agents, Non-Steroidal adverse effects
Anti-Inflammatory Agents, Non-Steroidal therapeutic use
Aryl Hydrocarbon Hydroxylases genetics
Cardiovascular Abnormalities chemically induced
Celecoxib
Cyclooxygenase 1 genetics
Cyclooxygenase 1 metabolism
Cyclooxygenase 2 genetics
Cyclooxygenase 2 metabolism
Cyclooxygenase 2 Inhibitors adverse effects
Cyclooxygenase 2 Inhibitors therapeutic use
Cytochrome P-450 CYP2C9
Genetic Association Studies
Humans
Metabolic Networks and Pathways genetics
Pyrazoles adverse effects
Pyrazoles therapeutic use
Sulfonamides adverse effects
Sulfonamides therapeutic use
Treatment Outcome
Anti-Inflammatory Agents, Non-Steroidal pharmacokinetics
Biomarkers, Pharmacological
Cyclooxygenase 2 Inhibitors pharmacokinetics
Inflammation drug therapy
Pyrazoles pharmacokinetics
Sulfonamides pharmacokinetics

Details

Language :

English

ISSN :

1744-6880

Volume :

22

Issue :

4

Database :

MEDLINE

Journal :

Pharmacogenetics and genomics

Publication Type :

Academic Journal

Accession number :

22336956

Full Text :

https://doi.org/10.1097/FPC.0b013e32834f94cb